These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34775626)

  • 1. Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).
    Hartley C; Bulloch M; Penzak SR
    J Clin Pharmacol; 2022 May; 62(5):577-593. PubMed ID: 34775626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kratom (Mitragyna speciosa): Friend or Foe?
    Sethi R; Hoang N; Ravishankar DA; McCracken M; Manzardo AM
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
    Bowe A; Kerr PL
    J Psychoactive Drugs; 2020; 52(5):447-452. PubMed ID: 32546067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kratom: Substance of Abuse or Therapeutic Plant?
    Gorelick DA
    Psychiatr Clin North Am; 2022 Sep; 45(3):415-430. PubMed ID: 36055730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy.
    Harun N; Kamaruzaman NA; Mohamed Sofian Z; Hassan Z
    Neurosci Lett; 2022 Mar; 773():136500. PubMed ID: 35114335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance.
    Buresh M
    J Addict Med; 2018; 12(6):481-483. PubMed ID: 29944481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kratom policy: The challenge of balancing therapeutic potential with public safety.
    Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
    Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the Pharmacology and Legal Status of Kratom.
    Prozialeck WC
    J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic and clinical assessment of kratom.
    White CM
    Am J Health Syst Pharm; 2018 Mar; 75(5):261-267. PubMed ID: 29255059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kratom Dependence and Treatment Options: A Comprehensive Review of the Literature.
    Bin Abdullah MFIL
    Curr Drug Targets; 2020; 21(15):1566-1579. PubMed ID: 32682371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
    Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
    Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic and clinical assessment of kratom: An update.
    White CM
    Am J Health Syst Pharm; 2019 Nov; 76(23):1915-1925. PubMed ID: 31626272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth).
    Boyer EW; Babu KM; Adkins JE; McCurdy CR; Halpern JH
    Addiction; 2008 Jun; 103(6):1048-50. PubMed ID: 18482427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kratom (Mitragyna speciosa): A Case Review of Use Before and During Pregnancy.
    Faucher MA; Morillos S; Cordova P; McNeil-Santiel J; Onisko N; Adhikari EH; Nelson DB
    J Midwifery Womens Health; 2024; 69(1):144-149. PubMed ID: 37679866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kratom & Stimulant Co-Addiction: A Case Series and Brief Review.
    Sablaban IM; Gautam M
    J Addict Dis; 2023; 41(2):181-184. PubMed ID: 35441584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse Potential.
    Chang-Chien GC; Odonkor CA; Amorapanth P
    Pain Physician; 2017; 20(1):E195-E198. PubMed ID: 28072812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations.
    McCurdy CR; Sharma A; Smith KE; Veltri CA; Weiss ST; White CM; Grundmann O
    Expert Rev Clin Pharmacol; 2024; 17(2):131-142. PubMed ID: 38217374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?
    Ismail I; Wahab S; Sidi H; Das S; Lin LJ; Razali R
    Curr Drug Targets; 2019; 20(2):166-172. PubMed ID: 28443503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.
    Garcia-Romeu A; Cox DJ; Smith KE; Dunn KE; Griffiths RR
    Drug Alcohol Depend; 2020 Mar; 208():107849. PubMed ID: 32029298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.